Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Pacagnelli (Presidente Prudente, Brazil), A. Freire (Presidente Prudente, Brazil), A. Sabela (Presidente Prudente, Brazil), S. Cury (Botucatu, Brazil), R. Carvalho (Botucatu, Brazil), T. Mariano (Presidente Prudente, Brazil), Y. Motta (Presidente Prudente, Brazil), A. Cicogna (Botucatu, Brazil), K. Okoshi (Botucatu, Brazil). Late Breaking Abstract - Molecular mechanisms involved in early stage of pulmonary hypertension: experimental study. 3275

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Convergence of clinical and computational phenotypes for rare variant association study (RVAS) in pulmonary arterial hypertension Source: Virtual Congress 2021 – All about pulmonary arterial hypertension Year: 2021 Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Late Breaking Abstract - Persisting pulmonary impairment following severe SARS-CoV-2 infection, preliminary results from the CovILD study Source: Virtual Congress 2020 – Covering COVID - the best abstracts Year: 2020 Late Breaking Abstract - Hypoxia-induced responses to mimic ongoing remodelling processes in chronic lung diseases Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD. Source: International Congress 2017 – Late-breaking findings in pulmonary diseases Year: 2017 Late Breaking Abstract - A comprehensive analysis of endothelial cell markers in pulmonary fibrosis Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Late Breaking Abstract - Lung involvement is clue for recognizing severe dengue-A retrospective study Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - COVID-19 in patients with pulmonary hypertension: a national prospective cohort study Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Late Breaking Abstract - Contribution of STIM-activated TRPC-ORAI channels to the intermittent hypoxia-induced pulmonary hypertension Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Late Breaking Abstract - Systemic ferritin is an early disease biomarker for silicosis patients Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development Source: International Congress 2017 – Postnatal lung growth and development Year: 2017 Late Breaking Abstract - Tiotropium/olodaterol improves pulmonary function in patients with treatment naive COPD Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Late Breaking Abstract - The effect of altering gut microbiota on the development of pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm. Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020 Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017